Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",27146,103,1.19 [0.89-1.60],0.2326062650415307
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27698,145,0.95 [0.73-1.24],0.6978024920155643
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27454,996,1.14 [1.03-1.25],0.0090413970490105
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Candidiasis,27732,300,1.09 [0.91-1.30],0.351648716761977
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,26948,2730,1.07 [1.00-1.13],0.0363741312579717
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27205,2051,1.15 [1.08-1.23],2.7160130857468264e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,27521,994,1.15 [1.05-1.27],0.00363068055481
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,27645,44,0.80 [0.49-1.31],0.3722423654195352
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26480,622,1.14 [1.01-1.29],0.0333823616905933
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25614,608,1.26 [1.12-1.42],0.0001365053770804
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,25858,168,1.19 [0.95-1.50],0.1318215319188196
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,20659,1193,1.12 [1.03-1.23],0.0090238504271264
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,25611,282,1.14 [0.95-1.37],0.1535957024662329
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27684,1157,1.10 [1.01-1.21],0.0316482699114976
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Mycoses,27791,359,1.07 [0.91-1.25],0.4321529500551015
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27067,609,1.23 [1.09-1.39],0.0007345007986637
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27731,688,1.14 [1.02-1.28],0.0234205407602133
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26674,147,0.94 [0.72-1.22],0.6480726211246574
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,27833,32,1.35 [0.82-2.22],0.2416698761161744
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27644,601,1.15 [1.02-1.30],0.0274251108335126
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27673,72,0.94 [0.65-1.37],0.7612488994722219
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27739,172,1.27 [1.02-1.59],0.0359810041154751
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27723,156,1.25 [0.99-1.58],0.0649870392881523
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26787,329,1.18 [1.00-1.39],0.0482197085257815
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,26701,243,0.99 [0.81-1.22],0.943503840101851
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,26607,80,1.50 [1.10-2.04],0.0095217169012043
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,27806,53,0.65 [0.41-1.03],0.065171667469609
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27769,132,1.00 [0.76-1.31],0.9862816680712956
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral warts,27682,45,0.87 [0.53-1.41],0.5599549368989459
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],27688,51,1.12 [0.72-1.72],0.6221646827439707
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm,27542,316,1.08 [0.91-1.29],0.3768393321923188
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27743,77,1.13 [0.79-1.60],0.5068774846627644
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27721,77,1.55 [1.14-2.11],0.0054335632357172
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,12400,44,1.04 [0.65-1.66],0.867436419292022
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27644,1167,1.00 [0.91-1.09],0.9280790583044448
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of meninges,27821,49,1.48 [1.00-2.21],0.0518169062050708
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27796,49,1.65 [1.14-2.39],0.0085147578402217
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,27812,95,1.44 [1.08-1.92],0.0124547703997132
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of ovary,15370,99,1.03 [0.75-1.42],0.8535190490598845
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Ascending colon,27827,275,0.98 [0.81-1.18],0.8060005634135571
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Caecum,27823,206,1.03 [0.83-1.28],0.7715599012474887
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27767,57,1.13 [0.75-1.69],0.5623430834588679
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Descending colon,27826,177,0.91 [0.71-1.15],0.4229418100880064
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Rectum,27791,285,1.03 [0.86-1.24],0.7156916178418951
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27757,541,0.89 [0.77-1.02],0.0959068879741486
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Transverse colon,27826,305,0.95 [0.79-1.14],0.5618317393914971
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Carcinoma in situ of breast,13220,88,0.89 [0.63-1.27],0.5275698204266626
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",13267,101,0.90 [0.65-1.24],0.5221641775443369
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",24057,32,1.47 [0.90-2.39],0.1228396817779916
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",24061,36,1.03 [0.61-1.76],0.8987612239511696
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27789,110,0.91 [0.67-1.23],0.5234839222642004
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Haemangioma, any site",27789,108,0.94 [0.69-1.28],0.6937437248392962
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Leiomyoma of uterus,14726,419,0.99 [0.85-1.16],0.931023186940655
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Lung cancer and mesothelioma,20687,175,1.53 [1.24-1.90],0.0001015626803639
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Lymphoid leukaemia,24054,29,2.16 [1.44-3.24],0.0002038709319587
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24173,148,1.10 [0.86-1.42],0.4459254349291094
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",24111,86,1.06 [0.76-1.48],0.7266943015145815
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",13320,81,0.83 [0.58-1.20],0.3167078694165837
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",24076,51,0.84 [0.53-1.32],0.4484747464721099
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",24088,63,1.17 [0.80-1.72],0.4163853289529602
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",24096,71,1.03 [0.72-1.49],0.8664002603115536
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",13293,54,1.20 [0.80-1.82],0.383207471944847
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",24085,60,1.14 [0.77-1.69],0.5117230133301581
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",11200,414,0.96 [0.82-1.13],0.642899590020696
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",24116,91,0.92 [0.65-1.28],0.6059232596714496
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",24080,55,1.38 [0.94-2.03],0.1051336827409503
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,24088,63,0.83 [0.55-1.26],0.3784300596842999
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Melanocytic naevi,27587,212,1.07 [0.87-1.33],0.5201804118310429
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Melanocytic naevi of trunk,27782,94,1.18 [0.87-1.61],0.2888453295811102
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Melanoma in situ,24041,51,1.01 [0.65-1.57],0.973408937806024
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",24084,59,1.03 [0.68-1.55],0.884126256828929
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",24142,117,1.23 [0.94-1.63],0.1332412984509189
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",24145,120,1.27 [0.96-1.67],0.0897141428953791
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",24094,69,1.14 [0.79-1.65],0.4796419016494123
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Other benign neoplasms of skin,27646,142,1.14 [0.88-1.47],0.3326209995445556
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",24671,646,1.03 [0.91-1.17],0.6356594995682475
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",24701,676,1.01 [0.90-1.15],0.8243576345613359
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27567,285,1.07 [0.89-1.28],0.4832222744348319
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,26419,58,1.61 [1.14-2.28],0.0068267412641869
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,27351,69,1.12 [0.78-1.62],0.5354141501446636
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,27034,2237,1.14 [1.07-1.22],6.357419178182562e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,26639,23,1.06 [0.56-2.02],0.8631911031464337
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,27483,35,0.75 [0.42-1.31],0.3065261106683931
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27389,1028,1.12 [1.02-1.24],0.0172161131066906
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27389,1028,1.12 [1.02-1.24],0.0172161131066906
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,26418,57,1.27 [0.86-1.87],0.2307716878512035
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27550,934,1.20 [1.09-1.32],0.0002744381982379
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,27560,112,0.83 [0.61-1.12],0.2238454383721707
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27334,52,0.90 [0.58-1.40],0.6554102292533259
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,27324,42,1.79 [1.22-2.64],0.0030951628610899
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,27638,190,0.79 [0.63-1.01],0.0596359957585892
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,27751,71,1.35 [0.96-1.90],0.087680273390192
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",27607,159,0.74 [0.57-0.96],0.0252724440375328
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,26690,74,0.94 [0.65-1.36],0.7386186679104223
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,23929,212,1.28 [1.05-1.56],0.0128107405018008
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,25906,127,0.79 [0.60-1.05],0.1066777582938502
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,25915,136,0.79 [0.61-1.02],0.0741496425175215
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,23756,39,1.19 [0.74-1.90],0.4658625619012067
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,25841,71,0.90 [0.62-1.32],0.5911392816147023
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,25508,153,1.06 [0.83-1.37],0.6297682173748141
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",27687,172,1.14 [0.91-1.44],0.2577399618728935
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,27562,47,1.00 [0.63-1.59],0.9952778409325764
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,27551,36,0.67 [0.38-1.18],0.1691650554453247
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,27422,1652,1.16 [1.08-1.25],6.599893419677833e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,24937,1604,1.17 [1.09-1.26],3.11247101670464e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",23755,38,1.14 [0.70-1.86],0.5932364967534609
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",26140,57,1.03 [0.68-1.55],0.904945654923488
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,23906,189,1.41 [1.15-1.73],0.0008222740319145
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,23777,60,1.37 [0.96-1.97],0.0859259347237443
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,26113,2396,1.22 [1.15-1.30],1.4678246722076576e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,23835,118,1.18 [0.90-1.55],0.2374781961476886
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,24100,383,1.32 [1.14-1.53],0.0001990241135588
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27728,278,1.31 [1.10-1.56],0.0026984548793721
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,27566,116,1.49 [1.15-1.93],0.0024288140841608
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,23811,94,1.38 [1.04-1.85],0.0267892336945232
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",23755,38,1.09 [0.66-1.79],0.7477027433840653
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27405,1322,1.14 [1.05-1.24],0.0024646223153594
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,23847,130,1.36 [1.06-1.73],0.014473435105558
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,23883,166,1.35 [1.09-1.68],0.0069270199595936
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",24114,397,1.30 [1.12-1.50],0.0005026482089425
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,23777,60,0.94 [0.62-1.42],0.7618227290301609
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,27559,109,1.52 [1.17-1.98],0.0019635894579835
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,24014,297,1.17 [0.98-1.39],0.085059481751705
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,24014,297,1.02 [0.85-1.22],0.8452292420223385
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,25414,59,1.11 [0.75-1.66],0.5975649782184389
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,27135,3418,1.18 [1.12-1.24],4.803171447912542e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,26120,37,0.75 [0.44-1.29],0.3031462391805519
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,26145,62,0.99 [0.66-1.48],0.9491493130973117
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,27648,1935,1.05 [0.98-1.12],0.205789397201462
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",27653,1933,1.05 [0.98-1.13],0.1847709602521848
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,26120,37,1.16 [0.70-1.92],0.5689494242004385
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,27510,1255,1.09 [1.00-1.18],0.0618895798205388
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",24612,895,1.19 [1.07-1.31],0.0007639005400205
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,27823,135,1.45 [1.15-1.84],0.0017686945885625
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,27549,34,0.97 [0.56-1.66],0.8979609499073278
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,26344,89,1.28 [0.94-1.74],0.1120669926004145
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,26372,117,1.33 [1.02-1.74],0.0366654147695252
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",23852,135,1.37 [1.07-1.75],0.0125010491545689
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26030,124,1.58 [1.23-2.02],0.0002698448167273
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1715,70,1.24 [0.86-1.78],0.2564841833001673
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1827,197,1.16 [0.93-1.44],0.2006605315013658
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,25946,40,1.72 [1.15-2.58],0.0087832839751451
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1683,38,1.85 [1.20-2.84],0.005353302652315
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27410,1504,1.44 [1.34-1.55],3.78193114345883e-24
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,27586,71,0.96 [0.66-1.40],0.8291592774853553
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,25631,276,0.91 [0.75-1.11],0.3478188380901573
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,24128,411,1.35 [1.17-1.55],3.141068443998991e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27747,177,0.98 [0.78-1.24],0.8747106843248968
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),27095,56,1.32 [0.90-1.94],0.1520171550263853
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Angina pectoris,26547,790,1.19 [1.07-1.32],0.0016182145068901
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Aortic aneurysm,27143,104,1.19 [0.89-1.59],0.2457860804740882
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,27070,31,1.80 [1.19-2.73],0.0051175719613367
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",27145,106,1.65 [1.30-2.10],4.8361429716939725e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,19868,939,1.06 [0.96-1.17],0.2583206160796624
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,AV-block,25350,184,0.93 [0.74-1.18],0.5481694167851936
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27799,256,1.22 [1.02-1.47],0.0312481733968168
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Cardiac arrest,19042,113,1.22 [0.93-1.61],0.1531517631273265
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25302,136,1.11 [0.86-1.44],0.428919269686433
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",25247,81,1.18 [0.85-1.65],0.321711188629419
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,27835,20,0.75 [0.36-1.55],0.4352992211071819
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Conduction disorders,25695,529,1.00 [0.87-1.15],0.9876677747320288
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,27108,1362,1.24 [1.14-1.34],1.2827210916134098e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,25879,6053,1.08 [1.04-1.12],0.0002305698813812
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26677,185,0.97 [0.77-1.23],0.8171486275110957
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Endocarditis,25210,44,0.80 [0.48-1.31],0.3742148737341033
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27716,510,1.10 [0.96-1.26],0.1814089128575684
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertension,26457,4931,1.11 [1.06-1.16],3.948784821678788e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, essential",26473,4947,1.11 [1.07-1.16],1.3827099699286388e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27671,54,0.75 [0.48-1.18],0.2120146559032439
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",21612,86,1.09 [0.79-1.52],0.5970584251925204
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,21593,67,1.53 [1.11-2.12],0.0097750543619025
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypotension,27731,683,1.08 [0.96-1.21],0.2254788950519893
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,27308,65,0.99 [0.67-1.46],0.9669952980522388
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27270,1513,1.18 [1.09-1.27],3.822683347341841e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27604,302,1.36 [1.16-1.60],0.0002134999659678
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Left bundle-branch block,25358,192,1.13 [0.91-1.41],0.2588383436190768
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27577,601,1.17 [1.03-1.32],0.0132477694884801
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26246,489,1.24 [1.09-1.42],0.0011802141055125
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27777,119,1.36 [1.05-1.75],0.0196399929933678
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",27820,206,1.21 [0.98-1.48],0.0761074847228614
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Oesophageal varices,26531,39,0.76 [0.44-1.30],0.314400080003918
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other aneurysm,27087,48,1.04 [0.67-1.64],0.8543063476493761
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other arrhythmias,25403,237,1.10 [0.90-1.34],0.3539744074765195
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,27103,64,1.55 [1.12-2.14],0.0082635463705138
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27180,141,1.20 [0.93-1.54],0.1603229918461887
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,25294,128,0.95 [0.72-1.26],0.7211732479864248
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other disorders of veins,26564,72,1.02 [0.71-1.48],0.907586327253009
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,26539,47,1.26 [0.82-1.92],0.2916261511932054
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,27053,37,0.86 [0.50-1.47],0.5765143748097937
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,26580,88,0.75 [0.53-1.07],0.1169784918880354
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25750,584,1.14 [1.00-1.29],0.0439430733806972
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,27095,47,0.94 [0.59-1.49],0.7763897870410624
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27382,343,1.18 [1.00-1.38],0.0462858931449339
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27383,154,1.09 [0.85-1.39],0.5148896907013252
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",27253,237,1.25 [1.03-1.51],0.0251162591243085
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19175,246,0.97 [0.79-1.18],0.7373055572394938
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27220,206,1.46 [1.22-1.76],4.497126915570656e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26748,256,1.02 [0.84-1.24],0.821246994494035
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27571,342,1.09 [0.92-1.28],0.3154561844668047
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27793,336,1.14 [0.96-1.34],0.1268635500666229
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Right bundle-branch block,25341,175,0.92 [0.72-1.17],0.5058459315685304
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27379,150,1.06 [0.83-1.36],0.6380657195834655
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,27132,116,1.19 [0.90-1.56],0.2257180423938929
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27597,354,1.29 [1.11-1.51],0.0011685418479516
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27571,389,1.27 [1.09-1.47],0.0017902026034565
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,27284,54,1.19 [0.79-1.77],0.405152805015426
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,27094,56,1.04 [0.68-1.58],0.8556817246898836
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27443,141,1.18 [0.92-1.52],0.1917379781216499
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27158,182,1.20 [0.96-1.50],0.1093907890804917
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Varicose veins,26818,326,0.93 [0.78-1.11],0.4456267123778763
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,27048,49,1.22 [0.81-1.85],0.3420143969758315
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27663,538,1.06 [0.93-1.21],0.3746977046197207
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27678,374,0.70 [0.59-0.83],3.5798915872647754e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24828,1439,1.13 [1.04-1.22],0.0037722521944908
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Any mental disorder,27084,3695,1.12 [1.07-1.18],4.470581151613542e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27616,444,0.71 [0.61-0.83],1.916304214629642e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",25070,1681,1.17 [1.09-1.26],2.104069347331373e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23482,93,1.15 [0.84-1.57],0.3960728561614751
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Smoking dependency,27301,1525,1.23 [1.15-1.32],8.214256658587319e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",25161,1772,1.18 [1.10-1.26],1.2429194415728131e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Vascular dementia,27719,20,0.67 [0.31-1.44],0.3087722413263676
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Alzheimer disease,27836,66,0.87 [0.58-1.31],0.5090984664145252
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Bell's palsy,26158,73,0.83 [0.57-1.22],0.3475871198741326
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26563,478,1.10 [0.95-1.26],0.1967927281125851
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Cerebral cysts,27482,207,1.12 [0.91-1.39],0.2925824660700125
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27751,226,0.94 [0.76-1.16],0.5832076753466
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,27694,24,0.56 [0.28-1.12],0.1009988362283645
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,27820,52,1.59 [1.09-2.31],0.0163090953030238
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",27335,60,0.94 [0.62-1.42],0.7580738272925853
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Epilepsy,26264,260,1.07 [0.89-1.30],0.4667943162919463
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27350,1346,1.05 [0.97-1.15],0.2159131312397472
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,27806,268,1.05 [0.87-1.28],0.5917856628056137
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27315,1654,1.01 [0.93-1.09],0.8850714686778212
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Generalized epilepsy,27467,53,0.98 [0.64-1.50],0.9190964707125056
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Hemiplegia,27687,162,1.02 [0.80-1.30],0.8689346325674793
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Hydrocephalus,27321,46,1.58 [1.08-2.33],0.0186936741422033
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,27811,65,1.17 [0.80-1.69],0.4180728420891392
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,26164,79,0.99 [0.69-1.41],0.949177748205913
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,26172,87,1.40 [1.04-1.88],0.0271304158255709
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Memory loss,27683,73,0.92 [0.64-1.34],0.6764973997039252
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Migraine,26425,421,1.09 [0.94-1.27],0.2602387029330866
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27745,374,1.08 [0.92-1.27],0.3311923097957737
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Motor neuron disease,20284,96,1.04 [0.75-1.42],0.8309135141623193
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27641,145,1.02 [0.78-1.31],0.910062301064519
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27222,1137,1.09 [0.99-1.19],0.0715031278652728
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Neurological diseases,26404,3088,1.05 [1.00-1.11],0.0646597953213241
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,27742,72,0.89 [0.61-1.30],0.5394804390265935
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26477,392,1.18 [1.01-1.37],0.0352896192730394
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",27766,235,1.27 [1.05-1.53],0.0131023098981928
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23235,308,0.95 [0.80-1.14],0.6065385170180729
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,27335,60,0.97 [0.65-1.46],0.8947571976544579
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other disorders of nervous system,27385,110,0.80 [0.58-1.09],0.1601321383362297
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,27628,90,1.27 [0.94-1.73],0.1198003361577868
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other facial nerve disorders,26175,90,0.88 [0.62-1.23],0.4525702313119683
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other headache syndromes,26064,60,1.09 [0.73-1.62],0.6780936344736868
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other neurological diseases,27714,439,1.11 [0.96-1.28],0.1787757044209877
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other sleep disorders,26591,587,1.02 [0.90-1.16],0.774228315851754
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Parkinson's disease,27823,157,0.94 [0.73-1.22],0.664420966184663
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,27339,64,1.19 [0.82-1.75],0.359880115564761
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Restless leg syndrome,27834,44,1.50 [0.99-2.27],0.055816458148883
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Sleep apnoea,27588,513,1.07 [0.94-1.23],0.3169609674037393
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Small fibre neuropathy,27568,37,1.55 [1.01-2.38],0.043024224376074
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,27821,121,0.89 [0.66-1.19],0.4365898748255395
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,26117,32,1.56 [0.96-2.51],0.0703963416583741
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,27836,67,0.91 [0.61-1.36],0.6486101457109548
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),27706,19,0.69 [0.32-1.51],0.3547331055779762
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,27349,43,1.08 [0.67-1.73],0.7537290510645928
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,27482,214,0.98 [0.79-1.22],0.8773543916750995
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27745,198,1.48 [1.21-1.80],0.0001020530321454
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,27087,37,0.81 [0.47-1.39],0.4399293178975889
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,27127,77,0.92 [0.64-1.33],0.6757206956289163
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",27745,30,1.02 [0.57-1.81],0.9560003496537964
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,27633,65,1.34 [0.94-1.93],0.1091659733966365
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1690,45,1.97 [1.34-2.89],0.0005951124452183
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1998,85,1.18 [0.85-1.63],0.3317329113544996
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,27386,80,0.86 [0.60-1.23],0.4056246479584603
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27706,615,1.10 [0.97-1.24],0.154087212803496
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27531,481,0.92 [0.79-1.06],0.2588727365494864
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27187,137,0.83 [0.63-1.10],0.2029296117408832
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27742,474,1.01 [0.87-1.16],0.9285368479110312
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,27822,52,0.93 [0.59-1.45],0.7394216491186261
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,27668,400,0.96 [0.82-1.13],0.6176102032486402
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",27791,223,1.08 [0.87-1.33],0.4944546786640753
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,27774,125,0.99 [0.74-1.31],0.927961694392856
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,27068,18,0.58 [0.26-1.30],0.1871587312321679
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,27077,27,1.41 [0.82-2.40],0.2148527192717369
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,27082,32,0.80 [0.45-1.44],0.4609921432359103
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27786,391,0.98 [0.83-1.15],0.7799063603973692
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,27497,102,0.73 [0.52-1.02],0.0649026400705137
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,27294,26,0.82 [0.43-1.56],0.5409951275367508
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,27642,74,0.87 [0.60-1.28],0.4878806928978233
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,27717,149,1.16 [0.90-1.48],0.2599425944885528
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,27429,161,0.92 [0.72-1.19],0.5410910506686708
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,27723,74,1.01 [0.70-1.47],0.951928636028899
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27657,262,1.19 [0.99-1.43],0.0690539148597341
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,27425,119,1.36 [1.05-1.77],0.020362750577278
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,27121,1057,1.12 [1.02-1.23],0.0212277782347018
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,27691,123,1.16 [0.88-1.52],0.3043491476802916
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,27810,113,1.02 [0.75-1.37],0.9209808445626464
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27314,264,0.93 [0.76-1.13],0.438766967472003
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,27604,36,0.62 [0.35-1.09],0.0966076475421491
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,27805,35,0.85 [0.49-1.49],0.5783787466550383
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,27089,39,1.00 [0.60-1.66],0.985048369005342
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27166,116,1.00 [0.75-1.34],0.9936236278847768
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,27162,71,1.13 [0.79-1.63],0.4987109081309422
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,27329,61,1.23 [0.84-1.80],0.2896392407160206
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",27140,49,0.89 [0.56-1.41],0.6103759917452432
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,27450,55,0.88 [0.57-1.37],0.57734875332012
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",27487,92,1.10 [0.80-1.53],0.5512168066375935
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,27142,92,1.07 [0.77-1.49],0.6763080831860131
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,27215,124,1.12 [0.85-1.47],0.4247942991478655
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,27125,34,1.32 [0.81-2.14],0.2675032134025968
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,26898,834,1.07 [0.96-1.19],0.2459762000563575
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,27100,50,0.74 [0.46-1.20],0.2227667812945656
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27620,314,1.09 [0.91-1.29],0.3537548076422862
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,27343,37,1.05 [0.63-1.75],0.8425764425875084
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),27432,126,1.17 [0.89-1.53],0.2600709251916732
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,27640,61,0.86 [0.56-1.30],0.4743331936263882
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,27793,96,0.85 [0.61-1.18],0.324367735094312
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,27717,135,1.28 [1.00-1.65],0.0512884721645144
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,27633,54,1.35 [0.91-1.99],0.1367271754254596
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,27632,53,1.09 [0.71-1.66],0.6920641359725705
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,27745,533,1.13 [0.99-1.29],0.0759639273994563
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,27545,333,1.22 [1.03-1.44],0.017688186232138
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,27307,95,0.98 [0.71-1.36],0.9036697868666684
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,27289,77,1.07 [0.75-1.53],0.695559303186357
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Acute pharyngitis,27547,80,0.99 [0.69-1.41],0.9445522781324032
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27699,232,0.96 [0.78-1.18],0.6689877578393189
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,27527,60,1.04 [0.70-1.55],0.8505170141697826
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,All influenza,26525,78,1.15 [0.82-1.62],0.4228375331147103
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),26523,76,1.09 [0.77-1.55],0.6314815480711105
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Allergic asthma (mode),20639,127,1.07 [0.81-1.41],0.6469707238355402
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Allergic rhinitis,27680,317,1.07 [0.90-1.27],0.4728027793053543
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",22148,1777,1.08 [1.00-1.16],0.0463986658334415
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",22261,1749,1.08 [1.01-1.17],0.0333843501796408
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),27549,94,1.31 [0.98-1.76],0.0671863280909473
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",26505,58,1.45 [1.01-2.06],0.0423470568709397
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Bronchiectasis,24775,184,1.26 [1.01-1.56],0.0384194520566712
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",24634,43,1.17 [0.74-1.83],0.5042182514244267
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26964,2373,1.12 [1.05-1.19],0.0006030961500194
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26339,64,1.00 [0.68-1.48],0.9958801679296476
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Chronic sinusitis,26446,171,1.37 [1.10-1.70],0.0047442265131885
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27728,721,1.12 [1.01-1.25],0.0344444378491276
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Deviated nasal septum,26405,130,1.24 [0.96-1.61],0.0941700490337053
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25906,4292,1.10 [1.05-1.15],7.40834434478914e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26657,382,1.09 [0.93-1.28],0.2722983294456536
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Early onset COPD,27515,508,1.19 [1.04-1.35],0.0085352313824348
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Emphysema,24776,185,1.48 [1.23-1.79],4.511493935537555e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26578,115,1.28 [0.98-1.68],0.0696432231993678
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27653,1206,1.09 [1.00-1.20],0.0433419946180915
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Interstitial lung disease,26603,140,1.18 [0.92-1.52],0.1981097003634614
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Later onset COPD,26391,213,1.01 [0.82-1.24],0.961125067301506
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,27827,156,0.90 [0.70-1.16],0.4185585301028559
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Nasal polyp,26386,111,1.29 [0.98-1.70],0.0671775487833988
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27623,621,1.15 [1.02-1.29],0.0270270483187891
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other diseases of pleura,27657,1250,1.11 [1.02-1.21],0.0166333691256664
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27177,902,1.13 [1.03-1.25],0.0146602158700601
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other pleural conditions,26442,35,0.96 [0.56-1.64],0.872600553889388
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27778,198,1.11 [0.90-1.38],0.3269010348393202
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27751,851,1.16 [1.05-1.29],0.0035537280818589
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pleural effusion,27005,598,1.06 [0.94-1.21],0.3277387406985683
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pleural plaque,26464,57,0.90 [0.59-1.38],0.6274359377209178
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27443,996,1.10 [1.00-1.21],0.049475159441933
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,27807,136,0.85 [0.64-1.12],0.2462908345366139
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pneumothorax,26471,64,1.27 [0.88-1.83],0.1946864525857709
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pollen allergy,27800,271,1.04 [0.86-1.26],0.6724323948269051
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pulmonary oedema,27618,38,1.29 [0.81-2.06],0.2845378304886207
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Respiratory insufficiency,20550,38,0.87 [0.52-1.46],0.6010818488052929
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27603,601,1.12 [0.99-1.26],0.082749580549955
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26592,317,1.07 [0.90-1.27],0.4424037165840775
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Viral pneumonia,26641,194,1.15 [0.92-1.43],0.2206923784065582
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",27568,168,1.06 [0.83-1.35],0.6440177703437975
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16076,104,1.05 [0.77-1.42],0.7744214341797508
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21326,65,0.88 [0.59-1.30],0.5265552694604835
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute appendicitis,27633,159,0.77 [0.59-1.00],0.0493003294416017
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute gastritis,22258,75,0.95 [0.66-1.38],0.7960048809552609
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute pancreatitis,26237,165,0.87 [0.68-1.12],0.2769175477964269
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute peritonitis,27401,74,0.95 [0.66-1.38],0.8015068436781358
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Alcoholic liver disease,27047,79,0.77 [0.54-1.10],0.1547683511018354
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Barrett oesophagus,22534,351,1.00 [0.84-1.18],0.9772275652434368
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",26125,53,1.39 [0.94-2.05],0.0971194569437698
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",27428,53,1.38 [0.94-2.04],0.101045531787619
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Cholecystitis,26253,181,1.19 [0.95-1.49],0.1252538638378759
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Cholelithiasis,26979,907,1.11 [1.00-1.23],0.0460917717092804
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Chronic gastritis,22442,259,1.14 [0.95-1.38],0.1636171577476901
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Chronic pancreatitis,26116,44,0.98 [0.62-1.56],0.9412413788932444
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",27694,77,0.94 [0.66-1.35],0.7454240101423765
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Coeliac disease,26407,118,1.41 [1.09-1.84],0.0094826360138001
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Collagenous colitis,26251,58,1.25 [0.85-1.84],0.2595834237347788
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27654,209,1.04 [0.84-1.29],0.691988779547231
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Constipation,27614,1185,1.07 [0.98-1.17],0.1509058219470816
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Crohn disease,26290,97,1.21 [0.89-1.63],0.223916629078852
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27490,68,1.10 [0.76-1.60],0.612041676487362
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26287,94,1.19 [0.87-1.62],0.2751105876569849
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Dental caries,26993,265,1.22 [1.02-1.46],0.0293347335893628
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,25750,1840,1.08 [1.01-1.16],0.0328049417689523
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of appendix,27676,202,0.93 [0.75-1.17],0.5536519081599044
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of liver,27717,749,1.05 [0.94-1.18],0.3650047371921727
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",26106,3923,1.06 [1.01-1.11],0.0214419667232078
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27344,616,1.16 [1.02-1.31],0.0187134436116913
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27757,430,1.16 [1.00-1.34],0.0455277033654007
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26861,133,1.20 [0.93-1.55],0.166540909360741
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of salivary glands,26698,71,0.76 [0.52-1.13],0.1783679892070859
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27556,1267,1.07 [0.98-1.17],0.1126114818639172
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of tongue,26709,122,1.07 [0.81-1.41],0.6422852133187715
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27317,1245,1.07 [0.98-1.17],0.1265579204250642
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,23720,2459,1.07 [1.00-1.13],0.0466110960733878
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Duodenal ulcer,22327,144,1.12 [0.87-1.44],0.3853426451791037
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27763,113,0.97 [0.73-1.30],0.8500554375698383
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27697,81,1.08 [0.77-1.53],0.6513600290220932
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,27066,98,1.01 [0.73-1.39],0.9488653559484934
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,21441,180,1.03 [0.82-1.31],0.7720426830288294
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Functional dyspepsia,22700,517,1.07 [0.94-1.23],0.3160777470337627
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastric ulcer,22466,283,1.04 [0.87-1.26],0.6411655253743831
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,24456,2273,1.09 [1.02-1.16],0.0087228185455855
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,22592,409,1.09 [0.94-1.27],0.2497806464880373
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,22748,8159,1.07 [1.03-1.10],0.0003569661976555
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,GI-bleeding,27309,1020,1.04 [0.94-1.15],0.4396160073889237
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,26791,63,1.08 [0.73-1.59],0.6958430120290431
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,22202,1307,1.11 [1.02-1.21],0.0183211185960274
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",27024,56,1.10 [0.73-1.64],0.6586732998192293
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Hernia,26679,2769,1.06 [1.00-1.12],0.0670831782794585
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Impacted teeth,27706,75,1.15 [0.81-1.64],0.4432647117190306
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Impaction of intestines,21293,32,1.40 [0.86-2.29],0.1749768375527031
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Inguinal hernia,24596,686,1.02 [0.90-1.15],0.7677614960361205
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",23986,76,0.88 [0.61-1.29],0.5242594289388437
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,21332,71,0.93 [0.63-1.35],0.6886766340718855
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26428,139,1.44 [1.14-1.83],0.0026084807176648
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,21836,575,1.10 [0.97-1.25],0.1376172627159019
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,27809,393,1.11 [0.95-1.29],0.1805260743549561
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26906,713,1.14 [1.01-1.27],0.0292686086357736
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27092,899,1.12 [1.01-1.24],0.0264231142997149
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22334,151,1.11 [0.86-1.42],0.4258028409311022
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oesophagitis,22676,493,1.15 [1.00-1.32],0.0473345999166302
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27791,136,1.16 [0.90-1.50],0.2595079629479894
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,23959,49,1.46 [0.99-2.16],0.0574556591450535
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,22563,1302,1.08 [0.99-1.18],0.0672215864671564
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26267,195,1.10 [0.89-1.37],0.3855058164628796
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,26234,162,0.98 [0.77-1.26],0.9044369059493492
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of intestine,22766,1505,1.01 [0.93-1.09],0.8735914014585867
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of intestines,26193,4932,1.05 [1.01-1.10],0.0205144350580801
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26703,202,1.09 [0.88-1.35],0.4410808639599896
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of liver,27575,607,1.07 [0.95-1.22],0.2660420669249508
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,22723,540,1.09 [0.95-1.24],0.216766388782173
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of pancreas,26156,84,0.90 [0.63-1.27],0.5407771318225612
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27700,373,1.21 [1.03-1.41],0.0177088154475406
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,22973,790,1.09 [0.98-1.22],0.1203187164864401
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27323,1034,1.04 [0.94-1.14],0.4771360224940012
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26917,189,1.16 [0.93-1.45],0.1769360787528711
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,22490,1229,1.07 [0.98-1.16],0.1529618890859188
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),23976,1793,1.06 [0.99-1.14],0.1188908328883683
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,27049,81,0.98 [0.69-1.40],0.9279292383369574
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26978,785,1.11 [1.00-1.24],0.0601993549433828
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21496,235,1.15 [0.94-1.40],0.1644555844984787
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27681,95,1.14 [0.83-1.56],0.4158452370772943
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21612,351,1.09 [0.93-1.28],0.3020285616070287
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26423,134,1.00 [0.77-1.32],0.978913657925603
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Recurring oral aphthae,27826,61,1.32 [0.91-1.92],0.1392148533080325
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,26747,133,1.11 [0.85-1.44],0.4486418104151003
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Toxic colitis,26225,32,0.89 [0.51-1.58],0.6984211973016328
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22363,180,1.05 [0.83-1.33],0.6703457539344122
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ulcerative colitis,26339,146,1.30 [1.02-1.65],0.0362008774647136
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26318,125,1.25 [0.96-1.63],0.0993764111471762
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Umbilical hernia,24196,286,0.93 [0.77-1.13],0.4600130661869119
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,21365,104,1.12 [0.83-1.50],0.4671889572919701
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ventral hernia,24140,230,1.12 [0.92-1.37],0.2677349761618808
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Volvulus,21325,64,0.87 [0.58-1.30],0.4817606866610283
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,27779,159,0.99 [0.77-1.28],0.9429514361833836
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,27562,81,0.81 [0.56-1.16],0.2467798239939503
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,26334,149,1.00 [0.77-1.29],0.9856800619472657
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27206,549,1.01 [0.88-1.15],0.8880713666289772
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26855,198,0.98 [0.78-1.22],0.8259572173774699
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,26365,180,1.12 [0.90-1.41],0.3091112275494779
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,27577,233,1.09 [0.89-1.33],0.4197273583673246
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27737,393,1.10 [0.94-1.28],0.2381874076426225
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,27392,48,1.49 [1.00-2.21],0.0513334390425756
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26360,2590,1.01 [0.95-1.08],0.7019171244463197
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27379,442,0.93 [0.80-1.08],0.3640917275402773
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27253,316,0.97 [0.81-1.15],0.7019431696197755
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27441,784,1.00 [0.90-1.12],0.9625588254233968
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",27822,47,1.33 [0.86-2.04],0.2006223384414183
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,26240,55,0.84 [0.54-1.30],0.4291120777014727
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26977,40,0.98 [0.60-1.62],0.9497471861035764
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,27571,227,1.09 [0.89-1.34],0.3873709109005093
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26477,292,1.13 [0.94-1.35],0.1859808148294999
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,26222,37,1.44 [0.91-2.27],0.1166207839895092
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,27754,69,1.25 [0.87-1.78],0.2218991118768843
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,26794,137,1.28 [1.00-1.64],0.0480522079693338
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27638,157,0.67 [0.51-0.88],0.0035544706803442
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27376,32,0.74 [0.41-1.33],0.3162616668659552
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,26237,52,1.14 [0.75-1.75],0.5350724120459912
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27304,1119,1.07 [0.98-1.17],0.1520966564833328
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26508,323,1.14 [0.96-1.35],0.1256633692583109
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,26226,41,1.49 [0.98-2.28],0.0650513138804039
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27752,271,0.80 [0.65-0.97],0.0257183882072983
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,27403,59,0.91 [0.60-1.39],0.6758694105954924
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27704,223,0.73 [0.59-0.91],0.0058889667307974
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27802,182,0.98 [0.78-1.24],0.8772310169722972
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,26308,123,1.00 [0.75-1.33],0.9772385350394396
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26376,191,0.96 [0.76-1.21],0.7045276955139421
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27793,173,0.94 [0.74-1.21],0.6498785867239444
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",26317,132,1.38 [1.09-1.74],0.0073976900906711
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,27802,117,1.21 [0.92-1.60],0.1801914460039752
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,24436,138,1.31 [1.02-1.68],0.0314051208109805
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,25995,4708,1.01 [0.97-1.06],0.5948359541963437
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,24609,3322,1.00 [0.95-1.06],0.90958468128242
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,24394,96,0.94 [0.68-1.30],0.7066884288409381
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,24970,156,0.99 [0.77-1.27],0.9324889898101394
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,24978,164,1.23 [0.98-1.56],0.0768898130114942
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,27606,117,0.87 [0.64-1.17],0.358952187818199
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",24862,48,0.73 [0.45-1.18],0.2007361928717739
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,22041,754,1.03 [0.92-1.15],0.6247183446659936
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27776,122,1.13 [0.85-1.49],0.3992889859786772
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,25109,295,1.13 [0.94-1.35],0.1927868579493614
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,24351,6311,1.04 [1.00-1.08],0.0466582254495248
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,26446,107,0.81 [0.59-1.11],0.1902625565645797
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,24416,118,0.91 [0.68-1.22],0.5136164504551366
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24913,615,1.02 [0.90-1.16],0.7528303244884669
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26940,2126,1.11 [1.04-1.19],0.0016353048617699
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24522,224,0.79 [0.63-0.99],0.0394321699694709
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,24584,286,1.21 [1.02-1.45],0.0322261308482179
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,24448,150,0.97 [0.74-1.25],0.7977439674744746
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,27316,36,1.27 [0.77-2.08],0.3457470075718339
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,22617,1330,0.99 [0.91-1.08],0.8647203272345834
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,21684,397,1.06 [0.90-1.24],0.503285934689041
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27781,388,1.07 [0.91-1.25],0.4023758515351362
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21358,71,0.83 [0.56-1.23],0.3503445941303093
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),21635,348,0.91 [0.77-1.09],0.306708650385421
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24634,336,0.84 [0.70-1.00],0.0539488787537405
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,22062,775,1.07 [0.96-1.20],0.2187157746862819
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,24843,29,1.21 [0.69-2.10],0.5046677540186915
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25375,561,1.16 [1.02-1.32],0.0215542270866522
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,25100,286,1.19 [0.99-1.42],0.059958630852089
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,22011,724,1.06 [0.95-1.19],0.2940354258955333
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,24384,86,1.20 [0.87-1.66],0.276297605840995
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",24361,63,1.10 [0.75-1.62],0.6175247886837368
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,26398,59,1.71 [1.25-2.34],0.0008505377919068
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27498,1159,0.93 [0.85-1.02],0.1315271954753325
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26995,656,0.92 [0.81-1.04],0.2021750829597032
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27727,353,1.17 [1.00-1.37],0.0542148183383958
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,23079,1792,0.99 [0.92-1.07],0.8441805249346269
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,21368,81,1.15 [0.82-1.62],0.4214732260600761
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,24375,77,1.32 [0.95-1.83],0.0975921854519265
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,21314,27,0.68 [0.35-1.31],0.2454115539479411
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21400,113,0.94 [0.69-1.27],0.6899848651921295
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,26571,232,0.89 [0.72-1.10],0.2993924484534334
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,26584,245,0.90 [0.73-1.11],0.3131388332279575
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,27793,83,0.97 [0.69-1.36],0.8497483572441346
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",26400,1586,1.15 [1.06-1.24],0.0004207784892627
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,24421,123,1.15 [0.87-1.52],0.314351001979859
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21401,114,0.77 [0.57-1.06],0.105640183482774
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25454,640,1.18 [1.04-1.33],0.0075915143002947
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,23346,2059,0.99 [0.93-1.07],0.8619649160492515
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,27340,60,1.38 [0.95-1.99],0.0911306043716084
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,27810,77,0.82 [0.56-1.19],0.2887098175264125
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,24383,85,0.93 [0.66-1.32],0.7017214694893192
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25405,1107,1.13 [1.03-1.24],0.0079753678831134
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,24367,69,0.82 [0.55-1.21],0.3093871325838924
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,22426,1139,1.13 [1.03-1.24],0.0078320417526791
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,26439,100,0.91 [0.66-1.25],0.5538131684823693
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,24365,67,0.90 [0.60-1.34],0.5963455645136809
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,24930,116,1.04 [0.78-1.40],0.7688769303093379
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24703,405,1.15 [0.99-1.33],0.0752510158223428
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27487,207,1.11 [0.90-1.38],0.3375039106126242
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,25288,474,1.14 [0.99-1.31],0.0673839003398505
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27734,332,1.19 [1.01-1.40],0.0359330082511876
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,27817,37,0.93 [0.55-1.58],0.8011400197339029
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24507,209,1.02 [0.82-1.26],0.8883391665720262
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22342,606,1.08 [0.95-1.22],0.2463653458928918
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24795,497,1.02 [0.89-1.17],0.7752631741124419
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],24467,169,0.82 [0.64-1.06],0.1317035650662292
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",21324,37,1.00 [0.59-1.68],0.9957988089947424
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,23084,1797,1.08 [1.01-1.16],0.03276954965784
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,21750,463,0.99 [0.85-1.15],0.8833242193512626
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,27366,86,1.14 [0.82-1.59],0.4343607256310871
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",27761,51,1.01 [0.66-1.57],0.9546744138829908
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",26209,30,1.54 [0.93-2.56],0.0961580667676353
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,21366,79,0.80 [0.55-1.15],0.2303271533284815
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,24903,89,1.19 [0.87-1.64],0.2822030692183799
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,21643,356,1.17 [1.00-1.37],0.0523564865498274
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24570,272,1.00 [0.83-1.22],0.9604773645160308
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,25033,219,1.24 [1.01-1.52],0.0354936649329173
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,24920,106,1.13 [0.84-1.52],0.4262226242868323
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,23566,50,1.11 [0.72-1.71],0.6294188897073809
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",27820,40,0.91 [0.55-1.52],0.7296086728341966
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24910,612,1.01 [0.89-1.14],0.9125311837116906
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],27366,86,1.12 [0.80-1.57],0.4976243982303178
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,26733,2435,1.05 [0.98-1.12],0.1565505954766868
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",24409,111,1.05 [0.78-1.41],0.7569834247605871
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25176,362,1.23 [1.05-1.44],0.0093883940682502
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,26430,188,1.15 [0.92-1.43],0.2155206286322772
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,24967,153,1.10 [0.86-1.41],0.4470193523442088
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25890,1076,1.17 [1.06-1.28],0.0010618907295756
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25536,722,1.16 [1.04-1.30],0.0080803511911102
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],24342,44,1.43 [0.94-2.17],0.0914662430505073
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27426,146,0.92 [0.70-1.20],0.5196830109270578
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24457,159,1.20 [0.95-1.53],0.1311000139864625
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,24357,59,1.05 [0.70-1.58],0.8025430684465298
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),21324,37,0.69 [0.40-1.19],0.1828964595883664
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Acute renal failure,27265,866,1.24 [1.12-1.37],1.951699472627557e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11301,75,0.99 [0.68-1.44],0.9683547345952048
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,15039,77,0.91 [0.63-1.32],0.6170428436146358
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27538,321,1.09 [0.92-1.29],0.3382532088793137
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,27276,59,0.95 [0.62-1.45],0.813339596350512
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,27105,706,1.32 [1.18-1.47],6.462214818722286e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,27644,33,1.09 [0.64-1.86],0.7508614108050679
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,27655,190,1.27 [1.03-1.57],0.0280279968224646
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Cystitis,25619,165,1.01 [0.79-1.29],0.9131580579661528
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Dialysis,26463,64,1.78 [1.31-2.42],0.0002219410983591
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,12009,1144,0.99 [0.90-1.09],0.8184410909178768
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15169,207,0.96 [0.77-1.20],0.7114861180858396
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Endometriosis,11366,140,0.89 [0.67-1.17],0.3966348512400055
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",11622,396,0.99 [0.84-1.16],0.8783220746320427
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11655,429,1.21 [1.04-1.40],0.0114041140603308
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23469,4317,1.06 [1.01-1.11],0.0196954950924187
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,27682,71,1.49 [1.08-2.07],0.0163254434728906
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Hydrocele,10954,89,0.84 [0.59-1.20],0.3438599733187835
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,26312,225,1.29 [1.06-1.56],0.0116520821364354
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,11620,755,1.04 [0.93-1.17],0.4781202278282912
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15030,245,0.86 [0.70-1.06],0.1461256315374373
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),10973,108,0.96 [0.71-1.31],0.8116015129945342
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Irregular menses,15037,127,0.93 [0.70-1.23],0.5991064345954915
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Menorrhagia,11530,304,1.04 [0.87-1.25],0.6623164456492052
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,25520,66,1.35 [0.95-1.92],0.0956884676295035
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,12665,1439,1.03 [0.95-1.12],0.4332781605116336
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,10914,49,0.93 [0.59-1.48],0.772712519075827
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11331,105,1.27 [0.95-1.70],0.1015292945399793
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",27823,36,1.22 [0.74-2.01],0.4329644230823222
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",27830,48,0.80 [0.50-1.28],0.3490082659634524
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26965,1511,1.09 [1.01-1.18],0.0311624949531656
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,25921,467,1.03 [0.89-1.19],0.6568141394261877
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,15030,68,1.12 [0.77-1.63],0.546119806852055
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27782,317,1.38 [1.18-1.62],6.547445637282408e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,11020,155,0.76 [0.58-0.99],0.0424086881217288
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,10984,119,1.19 [0.91-1.56],0.2143613106809222
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,10941,76,1.01 [0.70-1.44],0.9744345216519732
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,27798,55,1.07 [0.70-1.63],0.751773126007456
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26545,1091,1.12 [1.02-1.23],0.0155565768810109
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,14913,128,0.91 [0.68-1.21],0.5190149074398865
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11311,85,1.41 [1.03-1.93],0.029754427380341
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11457,231,0.91 [0.74-1.13],0.3927506594702248
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11286,60,1.21 [0.82-1.79],0.3459236519931845
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11332,106,1.13 [0.84-1.53],0.4235869823673576
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26344,257,1.19 [0.98-1.43],0.0726264371017091
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,27578,113,1.42 [1.09-1.84],0.008940094258456
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11413,187,1.01 [0.80-1.27],0.9392028296437236
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11309,83,0.71 [0.49-1.03],0.0710363659604374
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11668,442,1.12 [0.97-1.30],0.1201392050540302
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,11295,69,1.18 [0.82-1.71],0.3715817734318464
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11612,386,1.10 [0.94-1.29],0.2368263043067983
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,27659,48,1.39 [0.92-2.09],0.1140461745160293
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",10971,106,1.10 [0.82-1.47],0.5357794021846999
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27629,1542,1.20 [1.11-1.29],3.889263414328004e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",26230,143,1.16 [0.90-1.49],0.260139260649746
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,26478,79,0.97 [0.69-1.39],0.88710285303759
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27290,73,1.30 [0.93-1.82],0.1264107439782477
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Urethral stricture,25624,170,1.12 [0.88-1.41],0.3549214966325544
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27602,385,1.07 [0.92-1.26],0.3696976204662283
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11334,108,1.03 [0.76-1.40],0.8380181397752323
